WE DO NOT SHIP TO RESIDENTIAL ADDRESSES. For pricing in CAD/AUD/NZD please contact us.

Recombinant Mouse JAM2/CD322 Protein (His Tag)(Active) - PKSM040668

Recombinant Mouse JAM2/CD322 Protein (His Tag)(Active) - PKSM040668

Regular price
$1,024.80
Regular price
Sale price
$1,024.80
Unit price
per 
Availability
Sold out

Recombinant Mouse JAM2/CD322 Protein (His Tag)(Active) Size: 100μg Catalogue Number: PKSM040668-100 Citations, Manuals and MSDS Available upon request. Abbreviation: JAM2; CD322 Target Symptom: 1110002N23Rik; 2410030G21Rik; 2410167M24Rik; JAM-2; JAM-B; Jcam2; VE-JAM Target Species: Mouse Expression Host: HEK293 Cells Application: Cell culture; ELISA Fusion Tag: C-His Accession: NP_076333.3 Background: Junctional adhesion molecule B (JAM-B), also known as Junctional adhesion molecule 2 (JAM2), Vascular endothelial junction-associated molecule (VE-JAM), and CD322, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily. It is prominently expressed on high endothelial venules. expression to be restricted to the high endothelial venule of tonsil and lymph nodes. The localization to the endothelium of arterioles in and around inflammatory and tumor foci. JAM-B can function as an adhesive ligand for the T cell line J45 and can interact with GM-CSF/IL-4-derived peripheral blood dendritic cells, circulating CD56(+) NK cells, circulating CD56(+)CD3(+) NK/T cells, and circulating CD56(+)CD3(+)CD8(+) cytolytic T cells. JAM-2 is expressed on high endothelial venules (HEVs) in human tonsil and on a subset of human leukocytes, suggesting that JAM-2 plays a central role in the regulation of transendothelial migration. It binds to very late activation antigen (VLA)-4, a leucocyte integrin that contributes to rolling and firm adhesion of lymphocytes to endothelial cells through binding to vascular cell adhesion molecule (VCAM)-1. JAM-B appears to contribute to leucocyte extravasation by facilitating not only transmigration but also rolling and adhesion. JAM-B acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs. Activity: Measured by the ability of the immobilized protein to support the adhesion of Jurkat human leukemic T cells. When 8 x 104 cells/well are added to JAM2-coated plates (0.2 μg/ml and 100 μl/well), approximately 35-60% will adhere specifically after 60 minutes at 37℃. Sequence: Met 1-Asn 236 Purity: > 97 % as determined by reducing SDS-PAGE. Formulation: Lyophilized from sterile PBS, pH 7.4 Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. Reconstitution: Please refer to the printed manual for detailed information. Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method. Calculated MW: 24.7 kDa Observed MW: 37 kDa Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. Shipping: This product is provided as lyophilized powder which is shipped with ice packs. Research Use Only